Contrasting benefits of different artemisinin combination therapies as first-line mia treatments using model-based cost-effectiveness analysis Lucy C. Okell1, Matthew Cairns2, Jamie T. Griffin1, Neil M. Ferguson1, Joel Tarning3,4, George Jagoe5, Pierre Hugo5, Mark Baker5, Umberto D’Alessandro6,7,8, Teun Bousema9, David Ubben5 & Azra C ...
Get Price